33 min listen
New Treatment for IDH mt Gliomas
ratings:
Length:
18 minutes
Released:
Jul 20, 2023
Format:
Podcast episode
Description
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in The New England Journal of Medicine. Visit NPUb.org/Podcast for associated article links.
Released:
Jul 20, 2023
Format:
Podcast episode
Titles in the series (100)
September 11 2007 Issue: Mediterranean Diet and Alzheimer Disease Mortality by Neurology® Podcast